PMID: 41759565

CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment.

Gadelmawla Ahmed Farid, Hammad Noha, Atta Karim, Diaa Ahmed, Abouzkaly Fatma, Soni Kriti, Kelkar Raveena, Agrawal Siddharth P, Ahmed Raheel, Jain Hritvik

The American journal of cardiology · 2026

Vol. 267, pp. 28-37

View on PubMed DOI

This entry links to third-party literature. For research use only.

HumansSemaglutideGlucagon-Like PeptidesObesityRandomized Controlled Trials as TopicWeight Loss

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.